Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
07/2003
07/16/2003CN1430617A Process for producing carbostyril derivative
07/10/2003WO2003055850A1 β-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS
07/09/2003EP1324996A2 Substituted aryl ketones
07/09/2003EP1324986A1 Nitrogen-containing compounds and their use as glycine transport inhibitors
07/09/2003EP1324970A2 Retinoids for the treatment of emphysema
07/09/2003EP0966490B1 Catalyst compositions for the polymerization of olefins
07/09/2003CN1113874C Benzocycloalkylazolethione derivatives
07/08/2003US6590118 Used in treatment of and/or prevention of diabetes, especially non-insulin dependent diabetes (Type 2 diabetes)
07/08/2003US6590105 For skin lightening or depigmentation; works by inhibiting tyrosinase in humans; kits
07/08/2003CA2290501C Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof
07/08/2003CA2095615C Polyazamacrocyclic compounds for complexation of metal ions
07/03/2003WO2003053912A1 α-(N-SULPHONAMIDO)ACETAMIDE DERIVATIVES AS β-AMYLOID INHIBITORS
07/03/2003WO2003053368A2 Chalcone derivatives and their use to treat diseases
07/03/2003US20030125329 Treating atherosclerosis and other coronary artery diseases
07/03/2003US20030125328 Treating atherosclerosis and other coronary artery diseases
07/03/2003US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents
07/03/2003CA2470931A1 Chalcone derivatives and their use to treat diseases
07/02/2003EP1322626A1 Process for preparation of n-1 protected n ring nitrogen containing cyclic polyamines and products thereof
07/02/2003EP1322596A1 Zwitterionic tachykinin receptor antagonists
07/02/2003EP1322331A2 Fatty acid synthase inhibitors
07/02/2003EP0991627B1 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same
07/02/2003CN1427828A Substituted N-benzoyl-N'-(tetrazolylphenyl)-ureas and their use as pest control agents
07/01/2003US6586467 Tyrosine phosphatase inhibitors useful in the treatment or prevention of Type II Diabetes Mellitus
07/01/2003US6586433 Anticholesterol agents; antilipemic agents; cardiovascular disorders
07/01/2003US6585957 Medicinal aerosol formulation
06/2003
06/26/2003WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051357A1 Glucagon receptor antagonists/inverse agonists
06/26/2003US20030119833 Treating cardiovascular diseases
06/26/2003US20030119826 Neuroprotective treatment methods using selective iNOS inhibitors
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/24/2003US6583183 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
06/24/2003US6583182 Atomic numbers 21-30 are components of enzymes required for nucleic acid replication; substituted polyaza compounds inhibit cell replication by decreaseing bioavailability of iron or copper
06/24/2003US6583165 Anticarcinogenic, -inflammatory and -proliferative agents; viricides; bactericides; vascular restenosis, autoimmune diseases; psoriasis; anticolesterol and -lipemic agents
06/19/2003US20030114454 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/19/2003US20030114447 Controlling apoptosis; central nervous system disorders
06/19/2003US20030111148 Extracting the oxidizer with an aqueous nitric acid solution, containing not more than 55 weight percent of nitric acid; solvent-free; purification of solid propellants, explosives, and pyrotechnics
06/18/2003EP0757677B1 Benzocyclohexylimidazolethione derivatives
06/12/2003WO2003048135A1 Amorphous and crystalline forms of losartan potassium and process for their preparation
06/12/2003WO2003048109A1 Novel glucagon antagonists
06/12/2003WO2002064094A3 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
06/12/2003WO2002017712A3 Disubstituted benzenes as insecticides
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109528 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/12/2003US20030109522 Ophthalmologic treatment methods using selective iNOS inhibitors
06/12/2003US20030109459 Activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4. Such compounds are useful for treating diseases whose symptoms and/or damage are related to the binding of VCAM-1 to cells expressing VLA-4.
06/12/2003US20030108486 Macrocyclic metal complexes and their use for the production of conjugates with biomolecules
06/12/2003CA2672549A1 Amorphous and crystalline forms of losartan potassium and process for their preparation
06/12/2003CA2465597A1 Amorphous and crystalline forms of losartan potassium and process for their preparation
06/11/2003EP1317425A2 Resorcinol derivatives
06/11/2003EP1105372B1 Methoximinophenylacetic acid amides
06/10/2003US6576664 1-amido-2-hydroxy-substituted-indanes; suppressing production of tumor necrosis factor
06/10/2003CA2232775C Acyl compounds
06/05/2003US20030105148 Selective estrogen receptor modulators
06/05/2003US20030105100 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/05/2003US20030105092 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
06/03/2003CA2265559C Method for preparing 4-methyl-biphenyl derivatives
05/2003
05/29/2003US20030100559 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease
05/28/2003EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
05/28/2003EP1313714A1 Valsartan salts
05/28/2003EP0815090B1 Process for tetraazacycloalkane preparation
05/27/2003US6570022 Reacting a dicyanamide salt, an azide and water with strong acid
05/27/2003US6569897 Alkenyldiarylmethane non-nucleoside HIV-1 reverse transcriptase inhibitors
05/22/2003US20030096998 As immunomodulators and for inducing cytokine biosynthesis in animals, for therapy of viral infections
05/22/2003US20030096818 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/21/2003EP1311504A1 Tetrazolyl-phenyl acetamide glucokinase activators
05/21/2003EP1311499A2 Bicyclic compounds as h3 receptor ligands
05/21/2003EP1311493A1 Macrocyclic tetraamido ligands as bleaching catalysts and synthesis thereof
05/21/2003EP1311485A1 Processes for preparing cilostazol
05/21/2003EP1311482A2 Non-imidazole aryloxypiperidines as h3 receptor ligands
05/21/2003EP1311476A1 Aza-amino acid derivatives (factor x a?-inhibitors 15)
05/21/2003EP1115701B1 Arylsulfonanilide ureas
05/20/2003US6566381 For therapy of arthritis, cancer, cardiovascular disorder, skin disorder, ocular disorder, inflammation and gum disease
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003US20030092740 Anticoagulants
05/15/2003US20030092685 Administering a (bi- or tri)phenol compound containing a nitrogen ring
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/14/2003EP1309552A1 Compounds and inhibitors of phospholipases
05/14/2003EP1309549A1 Acetamide derivatives and the use thereof as inhibitors of coagulation factors xa and viia
05/14/2003EP0846117B1 Process for preparation of biphenyl derivatives
05/13/2003US6562807 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity
05/08/2003WO2003037328A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
05/08/2003US20030087905 Containing a haloalkyl group: e.g., 3-((3-(3-trifluoromethoxyphenoxy) phenyl)((3-(1,1,2,2-tetrafluoroethoxy)phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/07/2003EP1307237A2 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof
05/07/2003EP1307236A2 Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses
05/07/2003EP0749433B1 (4,4-difluorobut-3-enylthio)-substituted heterocyclic or carbocyclic ring compounds having pesticidal activity
05/07/2003CN1416422A Substituted benzoylcyclohexenones
05/02/2003EP1305299A1 Cyclic polyamine compounds for cancer therapy
05/02/2003EP0724387B1 Angiotension ii receptor antagonists for the treatment of chronic anti-inflammatory diseases
05/01/2003WO2003035627A1 Piperazine derivatives with ccr1 receptor antagonist activity
05/01/2003WO2003035626A2 Azole derivatives and pharmaceutical compositions containing them
05/01/2003US20030083500 Imidazonaphthyridines
05/01/2003US20030083341 2,3,5-Substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
05/01/2003US20030083331 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/01/2003CA2463101A1 Azole derivatives and pharmaceutical compositions containing them
04/2003
04/30/2003CN1414849A Carboxylic acid amides, medicaments containing these compounds and the use and preparation thereof
04/30/2003CN1414848A Prevention of plaque rupure by ACAT inhibitors
04/24/2003WO2003033480A1 Lactam derivatives as antagonists for human 11cby receptors
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 97